Johnson & Johnson plans to file for FDA approval of a nasal spray formula called esketamine this year. On Saturday, they presented new research suggesting the drug worked well alongside a traditional antidepressant for a month.

No comments

Read More About This Article: https://ift.tt/2IewbtM

No comments :

Post a Comment